Tafalgie Therapeutics
French tech company | Builders Republic
About
Clinical-stage biotech developing non-opioid painkillers based on a naturally secreted human protein that dampens pain signals between the peripheral and central nervous systems — targeting acute, chronic, neuropathic and post-operative pain without the addiction, sedation and tolerance risks of conventional opioids.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series A
- Founded
- 2020
- City
- MARSEILLE
- Region
- Provence-Alpes-Côte d’Azur
- Tracked rounds
- 1
- Amount raised
- 12 M€ raised since 2020
Funding rounds
- Series A — 2025
Investors
- Family Offices